Charles A. Sanders, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,334 shares at $27.13 ($91K) on 2008-05-13, disclosed to the SEC on 2008-05-15.
Scheduled sale ($91k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 700 | $19K | 20.8% |
| 2 | $27.03 | 300 | $8K | 8.9% |
| 3 | $27.07 | 400 | $11K | 11.9% |
| 4 | $27.08 | 200 | $5K | 6.0% |
| 5 | $27.13 | 300 | $8K | 9.0% |
| 6 | $27.19 | 500 |
| $14K |
| 15.0% |
| 7 | $27.27 | 300 | $8K | 9.0% |
| 8 | $27.46 | 300 | $8K | 9.1% |
| 9 | $27.70 | 334 | $9K | 10.2% |
| Total | $27.19 avg | 3,334 | $91K | 100% |
| Filing → |
| BIOD | BUY | 2011-08-11 | $12K | — | Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| BCRX | BUY | 2010-02-09 | $33K | — | Filing → |